This notice describes the privacy practices of Oakwood Lakes Podiatry Group regarding protected patient health information. It explains that patient information will only be used or disclosed for treatment, payment, or healthcare operations. It provides patients with rights regarding their health information, such as requesting restrictions on uses/disclosures, inspecting and copying records, and complaining about privacy violations. The notice takes effect on April 14, 2003.
A Gift to Your Family is designed to help you get started with future health care planning. It includes Wisconsin state forms to help you put your decisions in writing after you have discussed them with your family. We encourage you to execute a Power of Attorney for Health Care or a Declaration to Physicians (Living Will) before a
medical crisis occurs, and invite you to consider organ and tissue donation as you contemplate these important issues.
A Gift to Your Family is designed to help you get started with future health care planning. It includes Wisconsin state forms to help you put your decisions in writing after you have discussed them with your family. We encourage you to execute a Power of Attorney for Health Care or a Declaration to Physicians (Living Will) before a
medical crisis occurs, and invite you to consider organ and tissue donation as you contemplate these important issues.
The Statute of Limitations for Medical Negligence Cases in MichiganCullen McKinney
Health law attorney Cullen McKinney is a founding partner at Tanoury, Nauts, McKinney and Garbarino PLLC (TNMG). From his Detroit, Michigan, office Cullen McKinney defends clients in medical malpractice suits. Defense options can include that a suit is barred because the statute of limitations has elapsed.
Elderly care conference 2017 - culture, compassion and clinical neglect - fin...Browne Jacobson LLP
Professor Newdick focuses on; clinical culture, Mid Staffordshire and the influence of targets, reporting serious untoward incidents and understanding our clinical care culture.
Wondering what your rights are under the Health Insurance Portability and Accountability Act? Check out the new Notice of Privacy Practices effective 1 OCT 13.
The Statute of Limitations for Medical Negligence Cases in MichiganCullen McKinney
Health law attorney Cullen McKinney is a founding partner at Tanoury, Nauts, McKinney and Garbarino PLLC (TNMG). From his Detroit, Michigan, office Cullen McKinney defends clients in medical malpractice suits. Defense options can include that a suit is barred because the statute of limitations has elapsed.
Elderly care conference 2017 - culture, compassion and clinical neglect - fin...Browne Jacobson LLP
Professor Newdick focuses on; clinical culture, Mid Staffordshire and the influence of targets, reporting serious untoward incidents and understanding our clinical care culture.
Wondering what your rights are under the Health Insurance Portability and Accountability Act? Check out the new Notice of Privacy Practices effective 1 OCT 13.
Patient Consent Form | Alliance Physical TherapyAllianceRehab
At Alliance Physical Therapy we provide 24/7 access to online appointments, with most of the requests scheduled in less than 48 hours. We are able to serve the Northern VA and DC region.
Hammer Toes: American college of foot and ankle surgeons. An insight into what a hammertoe is and possible treatments for hammertoes including hammertoe correction surgery. via American College of Foot and Ankle Surgeons
A simple foot exam can reveal the first signs and symptoms of diabetes and identify more serious complications that could potentially lead to lower-limb amputations. via American Podiatric Medical Association (APMA)
Arthritis and your Feet: Understanding the different types of Arthritis, the symptoms associated with them and how to properly treat it. via American Podiatric Medical Association (APMA)
Toenails often serve as barometers of our health. They are diagnostic tools, providing the initial signal of the presence or onset of systemic diseases. For example, the pitting of nails and increased nail thickness can be manifestations of psoriasis. Concavity—nails that are rounded inward instead of outward—canforetell iron deficiency anemia. Some nail problems can be conservatively treated with topical or oral medications, while others require partial or total removal of the nail. Any discoloration or infection on or about the nail should be evaluated by a podiatric physician. via American Podiatric Medical Association
Plantar fasciitis is an inflammation of the long band of connective tissue running from the heel to the ball of the foot. Heel spur syndrome is a bony overgrowth on the heel bone. Plantar fasciitis and heel spur syndrome affect women more than men. They can cause the bottom of the heel and arch to become painful.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
1. NOTICE OF PRIVACY PRACTICES
THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW
YOU CAN GET ACCESS TO THIS INFORMATION.
PLEASE REVIEW IT CAREFULLY
I. OUR COMMITMENT TO YOUR PRIVACY
We understand that medical information about you is personal and confidential. Be assured that we are committed to
protecting that information. We are required by law to maintain the privacy of protected health information and to provide you
with this NOTICE of our legal duties and privacy practices with respect to protected health information. We are required by law
to abide by the terms of this Notice, and we reserve the right to change the terms of this Notice, making any revisions applicable
to all the protected information we maintain. If we revise the terms of this Notice, we will post a revised notice and make paper
and electronic copies of this Notice ofPrivacy Practices for Protected Health Information available upon request.
In general when we release your personal information, we must release only the information needed to achieve the purpose
of the use of disclosure. However all of your personal health information that you designate will be available for release if you
sign an authorization form, if you request the information for yourself, a provider regarding your treatment, or due to a legal
requirement.
II. HOW MAY WE USE AND DISCLOSE YOU PROTECTED HEALTH INFORMATION
For uses and disclosures relating to treatment, payment, or health care operations, we do not need an authorization to use
and disclose your medical information:
For treatment: We may disclose your medical information to doctors, nurses and other health care personal who are involved
in providing your health care. We may use your medical information to provide you and medical treatment or services. For
example you doctor may be providing treatment for arthritis and need to make sure that you don't have any other health
problems that could interfere. The doctor might use your medical history to determine what method of treatment (such drug
or surgery) is best for you. Your medial information might also be shared amount member of your treatment team, or with
your pharmacist(s).
To obtain payment: We may use and/or disclose your medical information in order to bill and collect payment for your health
care services or to obtain permission for an anticipated plan of treatment. For example, in order for Medicare or an insurance
company to pay for your treatment, we must submit a bill that identifies you, your diagnosis, and the services provided to
you. As a result, we will pass this type of health information on to an insurer to help receive payment for your medical bills.
For health care operations: We may use and/or disclose your medical information in the course of operating our practice. For
example, we may use your medical information in evaluating the quality of services provided, or disclose your medical
information to our accountant or attorney for audit purposes.
In addition, unless you object, we may use your health information to send you appointment reminders cards or information
about treatment alternatives or other health-related benefits that may be of interest to you. For example, we may look at your
record to determine the date and time of your next appointment with us and then send you a reminder or call to help you
remember the appointment. Or, we may look at your medical information and decide another treatment or new service we
offer may interest you.
We may also use and/or disclose your medical information in accordance with federal and state laws for the following purposes:
• We may disclose your medical information to law enforcement or other specialized government function
response to a court order, subpoena, warrant, summons, or similar process.
• We may disclose medial information when a law requires that we report information about suspected abuse,
neglect or domestic violence, or relating to suspected criminal activity, or in response to a court order. We must
also disclose medical information to authorities who monitor compliance with these privacy requirements.
| Contact us :: 561.364.5522 :: www.drmattison.com |
1 |BRAD S. MATTISON, DPM|SUSAN BAKST-MATTISON, DPM|
|OAKWOOD LAKES PODIATRY GROUP. P.A.|
2. • We may disclose medical information when we are required to collect information about disease or injury,
or to report vital statistics to the public health authority. We may also disclose medical information to the
protection and advocacy agency, or other agencies responsible for monitoring the health care systems for
such purposes as reporting or investigation of unusual incidents.
• We may disclose medical information relating to an individual's death to coroners medical examiners or funeral
directors, and to organ procurement organizations relating to organ, eye or disuse donations or transplants.
• In order to avoid a serious threat to health or safety, we may disclose medial information to law enforcement or
other persons who can reasonably prevent or lessen the threat of harm, or to help with the coordination of
disaster relief efforts.
• If people such as family members, relatives, or close personal friends are involved in your care or helping you
pay your medical bills, we may release important health information about you to those people. We may also
share medical information with these people to notify them about your location, general condition, or death.
• We may disclose your medical information as authorized by law relating to worker's compensation or
similar programs.
• We may disclose your medical information in the course of certain judicial administrative proceeding.
Other uses and disclosures of your medical information not covered by this notice or the laws that apply to us will be made only
with your written authorization. If you provide permission to use or disclose medical information about you, you may revoke that
permission, in writing at any time. You understand that we are unable to take back any disclosures we have already made with
your permission, and that we are required to retain our records of the care that we provided you.
III. YOUR RIGHTS REGARDING YOUR MEDICAL INFORMATION
You have several rights with regard to your health information. If you wish to exercise any of these rights, please contact
our Medial Records Department at (561-364-5522). Specifically, you have the following rights:
1. You have the right to ask that we limit how we use or disclose your medical information. You have the right to ask
that we sent you information at an alternative address or an alternative means. We will consider your request, but
are not legally bound to agree to the restriction. We will agree to your request as long as it is reasonably easy for us
to do so. We will not ask you the reason for your request. Your request must specify how or where you wish to be
contacted.
2. With few exceptions (such as psychotherapy notes or information gathered for judicial proceedings) you have a right
to inspect and copy your protected health information if you put your request in writing. If we deny your access, we
will give you written reasons for the denial and explain any right to have the denial reviewed. We may charge you a
reasonable fee if you want a copy of your health information. You have a right to choose what portions of your
information you want copied and to have prior information on the cost of coping.
3. If you believe that there is a mistake or missing information in our record of your medical information you may request
that we correct or add to the record. Your request must be in writing and give a reason as to why your health
information should be changed. Any denial will state reason for denial and explain your rights to have the request
and denial along with any statements in response that you provide appended to your medical information. If we
approve the request for amendment, we will amend the medical information and so inform you.
4. In some limited circumstances, you have the right to ask for a list of the disclosures of your health information we
have made during the previous six years, but the request cannot include dates before April 14, 2003. The list will
not include disclosures made to you; for purposes of treatment, payment or healthcare operations, which you
signed an authorization or for other reasons for which we are not required to keep a record of disclosures. There
will be no charge for up to one such list each year. There may be a charge for more frequent requests.
5. You have a right to receive a paper copy of this notice.
| Contact us :: 561.364.5522 :: www.drmattison.com |
2 |BRAD S. MATTISON, DPM|SUSAN BAKST-MATTISON, DPM|
|OAKWOOD LAKES PODIATRY GROUP. P.A.|
3. IV How To Complain About Our Privacy Practices
If you think we may have violated your privacy rights or you disagree with a decision we made about access to your medical
information, we encourage you to contact us. You may file a complaint with the person listed in Section V. below. You may
also file a written complaint with the Secretary of the U.S. Department of Health and Human Services at the Office of Civil
Rights Region IV office.
We will take no retaliatory action against you if you make such complaints.
V Contact person for information, Or To Submit A Complaint
Oakwood Lakes Podiatry Group P.A. Attention:
Privacy Officer
3695 Boynton Beach Blvd #4
Boynton Beach Florida, 33436
VI Effective Date: This notice was effective on April 14, 2003.
| Contact us :: 561.364.5522 :: www.drmattison.com |
3 |BRAD S. MATTISON, DPM|SUSAN BAKST-MATTISON, DPM|
|OAKWOOD LAKES PODIATRY GROUP. P.A.|